MERCY ROY: Open Payments
NPI 1558149476 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 8 payments from 5 companies in 2025. Trend: 2023 $151 · 2024 $293 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $262 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Nuvation Bio Inc. | 1 | $23 |
Products named: DATROWAY, KEYTRUDA, IMFINZI, OPDIVO, IBTROZI.
Industry payments across TX — which companies pay providers there.
